PlainRecalls
FDA Drug Low Class III Terminated

Fentanyl Buccal Tablets CII, 800mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-638-28

Reported: May 31, 2023 Initiated: April 27, 2023 #D-0770-2023

Product Description

Fentanyl Buccal Tablets CII, 800mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-638-28

Reason for Recall

Labeling: Incorrect or Missing Package Insert

Details

Units Affected
3032
Distribution
US Nationwide
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Fentanyl Buccal Tablets CII, 800mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-638-28. Recalled by Teva Pharmaceuticals USA Inc. Units affected: 3032.
Why was this product recalled?
Labeling: Incorrect or Missing Package Insert
Which agency issued this recall?
This recall was issued by the FDA Drug on May 31, 2023. Severity: Low. Recall number: D-0770-2023.